Allen S Ho1,2, Sungjin Kim1,3, Mourad Tighiouart1,3, Alain Mita1,4, Kevin S Scher1,4, Joel B Epstein1, Anna Laury1,5, Ravi Prasad1,6, Nabilah Ali1,2, Chrysanta Patio1,2, Jon Mallen-St Clair1,2, Zachary S Zumsteg1,7. 1. Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California. 2. Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, California. 3. Biostatistics and Bioinformatics Research Center, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California. 4. Division of Medical Oncology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California. 5. Department of Pathology, Cedars-Sinai Medical Center, Los Angeles, California. 6. Department of Radiology, Cedars-Sinai Medical Center, Los Angeles, California. 7. Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, California.
Abstract
BACKGROUND: Multidisciplinary management of head and neck cancer (HNC) must reconcile increasingly sophisticated subspecialty care with timeliness of care. Prior studies examined the individual effects of delays in diagnosis-to-treatment interval, postoperative interval, and radiation interval but did not consider them collectively. The objective of the current study was to investigate the combined impact of these interwoven intervals on patients with HNC. METHODS: Patients with HNC who underwent curative-intent surgery with radiation were identified in the National Cancer Database between 2004 and 2013. Multivariable models were constructed using restricted cubic splines to determine nonlinear relations with overall survival. RESULTS: Overall, 15,064 patients were evaluated. After adjustment for covariates, only prolonged postoperative interval (P < .001) and radiation interval (P < .001) independently predicted for worse outcomes, whereas the association of diagnosis-to-treatment interval with survival disappeared. By using multivariable restricted cubic spline functions, increasing postoperative interval did not affect mortality until 40 days after surgery, and each day of delay beyond this increased the risk of mortality until 70 days after surgery (hazard ratio, 1.14; 95% confidence interval, 1.01-1.28; P = .029). For radiation interval, mortality escalated continuously with each additional day of delay, plateauing at 55 days (hazard ratio, 1.25; 95% confidence interval, 1.11-1.41; P < .001). Delays beyond these change points were not associated with further survival decrements. CONCLUSIONS: Increasing delays in postoperative and radiation intervals are associated independently with an escalating risk of mortality that plateaus beyond certain thresholds. Delays in initiating therapy, conversely, are eclipsed in importance when appraised in conjunction with the entire treatment course. Such findings may redirect focus to streamlining those intervals that are most sensitive to delays when considering survival burden. Cancer 2018.
BACKGROUND: Multidisciplinary management of head and neck cancer (HNC) must reconcile increasingly sophisticated subspecialty care with timeliness of care. Prior studies examined the individual effects of delays in diagnosis-to-treatment interval, postoperative interval, and radiation interval but did not consider them collectively. The objective of the current study was to investigate the combined impact of these interwoven intervals on patients with HNC. METHODS:Patients with HNC who underwent curative-intent surgery with radiation were identified in the National Cancer Database between 2004 and 2013. Multivariable models were constructed using restricted cubic splines to determine nonlinear relations with overall survival. RESULTS: Overall, 15,064 patients were evaluated. After adjustment for covariates, only prolonged postoperative interval (P < .001) and radiation interval (P < .001) independently predicted for worse outcomes, whereas the association of diagnosis-to-treatment interval with survival disappeared. By using multivariable restricted cubic spline functions, increasing postoperative interval did not affect mortality until 40 days after surgery, and each day of delay beyond this increased the risk of mortality until 70 days after surgery (hazard ratio, 1.14; 95% confidence interval, 1.01-1.28; P = .029). For radiation interval, mortality escalated continuously with each additional day of delay, plateauing at 55 days (hazard ratio, 1.25; 95% confidence interval, 1.11-1.41; P < .001). Delays beyond these change points were not associated with further survival decrements. CONCLUSIONS: Increasing delays in postoperative and radiation intervals are associated independently with an escalating risk of mortality that plateaus beyond certain thresholds. Delays in initiating therapy, conversely, are eclipsed in importance when appraised in conjunction with the entire treatment course. Such findings may redirect focus to streamlining those intervals that are most sensitive to delays when considering survival burden. Cancer 2018.
Keywords:
diagnosis-to-treatment interval; head and neck cancer; postoperative interval; radiation treatment breaks; radiation treatment time; time to treatment initiation; treatment delay; treatment package time
Authors: Michel C van Harten; Mischa de Ridder; Olga Hamming-Vrieze; Ludi E Smeele; Alfons J M Balm; Michiel W M van den Brekel Journal: Oral Oncol Date: 2014-01-07 Impact factor: 5.337
Authors: Samir S Khariwala; Prashant P Vivek; Robert R Lorenz; Ramon M Esclamado; Benjamin Wood; Marshall Strome; Daniel S Alam Journal: Laryngoscope Date: 2007-08 Impact factor: 3.325
Authors: Colin T Murphy; Thomas J Galloway; Elizabeth A Handorf; Lora Wang; Ranee Mehra; Douglas B Flieder; John A Ridge Journal: Cancer Date: 2014-12-09 Impact factor: 6.860
Authors: Marko Simunovic; Eddy Rempel; Marc-Erick Thériault; Nancy N Baxter; Beth A Virnig; Neal J Meropol; Mark N Levine Journal: Can J Surg Date: 2009-08 Impact factor: 2.089
Authors: Chandler J Rygalski; Songzhu Zhao; Antoine Eskander; Sidharth V Puram; Stephen Y Kang Journal: Ann Surg Oncol Date: 2020-11-13 Impact factor: 5.344
Authors: Evan M Graboyes; Chanita Hughes Halbert; Hong Li; Graham W Warren; Anthony J Alberg; Elizabeth A Calhoun; Brian Nussenbaum; Courtney H Marsh; Jessica McCay; Terry A Day; John M Kaczmar; Anand K Sharma; David M Neskey; Katherine R Sterba Journal: JCO Oncol Pract Date: 2020-08-27
Authors: Allen S Ho; Michael Luu; Laurel Barrios; Bonnie L Balzer; Shikha Bose; Xuemo Fan; Evan Walgama; Jon Mallen-St Clair; Usman Alam; Iram Shafqat; De-Chen Lin; Yufei Chen; Jennifer E Van Eyk; Ellie G Maghami; Glenn D Braunstein; Wendy L Sacks; Zachary S Zumsteg Journal: Ann Surg Oncol Date: 2020-08-17 Impact factor: 5.344
Authors: Helmneh M Sineshaw; Mark A Ellis; K Robin Yabroff; Xuesong Han; Ahmedin Jemal; Terry A Day; Evan M Graboyes Journal: JAMA Otolaryngol Head Neck Surg Date: 2020-03-01 Impact factor: 6.223
Authors: Dylan A Levy; Hong Li; Katherine R Sterba; Chanita Hughes-Halbert; Graham W Warren; Brian Nussenbaum; Anthony J Alberg; Terry A Day; Evan M Graboyes Journal: JAMA Otolaryngol Head Neck Surg Date: 2020-05-01 Impact factor: 6.223
Authors: Angela L Mazul; Katelyn O Stepan; Thomas F Barrett; Wade L Thorstad; Sean Massa; Douglas R Adkins; Mackenzie D Daly; Jason T Rich; Randal C Paniello; Patrik Pipkorn; Jose P Zevallos; Ryan S Jackson; Stephen Y Kang; Sidharth V Puram Journal: Oral Oncol Date: 2020-05-30 Impact factor: 5.337
Authors: Evan M Graboyes; Katherine R Sterba; Hong Li; Graham W Warren; Anthony J Alberg; Elizabeth A Calhoun; Brian Nussenbaum; Jessica McCay; Courtney H Marsh; Nosayaba Osazuwa-Peters; David M Neskey; John M Kaczmar; Anand K Sharma; Jennifer Harper; Terry A Day; Chanita Hughes-Halbert Journal: JCO Oncol Pract Date: 2021-03-10